Skip to main content
. 2022 Dec 19;3:45. doi: 10.1186/s43556-022-00109-9

Fig. 5.

Fig. 5

Potential therapeutic strategies based on the TGF-β signaling pathway in disease. Antagonists targeting the TGF-β pathway, including neutralizing antibodies, ligand traps, small-molecule receptor kinase inhibitors, antisense oligonucleotides and vaccines, have recently been evaluated in clinical trials. Representative drugs are shown